Non-invasive tests for evaluation of liver disease severity and prognosis
Liver fibrosis is part of the structural and functional alterations in most chronic liver diseases. It is one of the […]
Clinical Practice Guidelines
EASL Recommendations on Treatment of Hepatitis C (2015)
Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide. The long-term impact of
Hepatic Encephalopathy in Chronic Liver Disease
Hepatic Encephalopathy (HE) is a frequent complication and one of the most debilitating manifestations of liver disease, severely affecting the
Management of Hepatitis C Virus Infection
Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide. The long-term impact of
ESPGHAN Clinical Practice Guidelines: Management of chronic hepatitis B in childhood
More than 360 million persons worldwide (6% of the world population) are chronically infected by the hepatitis B virus (HBV). Although
Management of Alcoholic Liver Disease
Alcoholic liver disease (ALD) is the most prevalent cause of advanced liver disease in Europe. However, there has been limited
EASL-EORTC Clinical Practice Guidelines: Management of Hepatocellular Carcinoma
These guidelines result from a joint collaboration between the European Association for the Study of the Liver (EASL) and the
Management of Chronic Hepatitis B 2012 Revised Version
April 2012, EASL’s revised CPGs on the Management of Chronic Hepatitis B (originally released in October 2008) now include; modified
Management of Wilson’s Disease
Recommendations are based on a systematic literature review in the Medline (PubMed version), Embase (Dialog version), and the Cochrane Library
Management of Hepatitis C Virus Infection
Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide. The long-term hepatic impact